Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Planned sale Director sold 22,000 shares at $9.07 ($199,617)
  2. 4 Planned sale SVP, Chief Accounting Officer sold 7,711 shares at $9.12 ($70,324)
  3. 4 Other disposition EVP & Chief Financial Officer disposed of 2,500 shares (other)
  4. 4 Planned sale Director sold 22,000 shares at an average $9.51 ($209,181)
  5. 4 Planned sale Director sold 42,377 shares at an average $9.75 ($413,366)
  6. 4 Planned sale SVP, Chief Accounting Officer sold 1,430 shares at $9.53 ($13,632)
  7. 4 Planned sale EVP & Chief Financial Officer sold 1,634 shares at $9.53 ($15,576)
  8. 4 Planned sale EVP and Chief Medical Officer sold 3,505 shares at an average $9.69 ($33,955)
  9. 4 Planned sale EVP, General Counsel, Corp Sec sold 16,817 shares at an average $9.77 ($164,247)
  10. 4 Planned sale Chief Executive Officer sold 14,762 shares at $9.53 ($140,720)
  11. 4 Planned sale SVP, Chief Accounting Officer sold 1,829 shares at $7.45 ($13,631)
  12. 4 Planned sale EVP & Chief Financial Officer sold 2,089 shares at $7.45 ($15,569)
  13. 4 Planned sale EVP and Chief Medical Officer sold 2,089 shares at $7.45 ($15,569)
  14. 4 Planned sale EVP, General Counsel, Corp Sec sold 4,445 shares at $7.45 ($33,128)
  15. 4 Planned sale Chief Executive Officer sold 19,039 shares at $7.45 ($141,894)
  16. 4 Planned sale SVP, Chief Accounting Officer sold 1,530 shares at $7.79 ($11,919)
  17. 4 Planned sale Director sold 22,000 shares at $7.71 ($169,671)
  18. 4 Planned sale Director sold 22,000 shares at $5.93 ($130,383)
  19. 4 Planned sale 10% owner sold 191,854 shares at $5.98 ($1,147,786)
  20. 4 Planned sale Director sold 22,000 shares at $6.00 ($132,070)

Page 2 of 25 · 491 filings